TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > North Carolina Investigators

Michael Morse, MD

Duke Cancer Research Institute, Duke ...


Durham, North Carolina - 27710 (919-971-0276)

Duke University Medical Center


Durham, North Carolina - 27710

Duke Comprehensive Cancer Center


Durham, North Carolina - 27710 (919-668-1409)
  • CLINICAL TRIALS 7
  • CONDITIONS17
  • INTERVENTIONS9
  • SINCE2007
Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA

June 2010 - June 2011
Phase I/II Trial of Radiation Avastin and Tarceva for Pancreatic Adenocarcinoma

July 2008 - December 2011
Immunotherapy Study for Surgically Resected Pancreatic Cancer

April 2010 - January 2014
A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian Breast and Prostate Cancer

March 2010 - May 2011
Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer

July 2009 - July 2011
Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

April 2008 - August 2011
A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML CML ALL MDS and B Cell Malignancies

June 2007 - June 2010
Breast Neoplasms

Colonic Neoplasms

Lung Neoplasms

Adenocarcinoma

Prostatic Neoplasms

Leukemia

Leukemia, Lymphoid

Neoplasms

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Leukemia, Myeloid, Acute

Leukemia, Myeloid

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Myelodysplastic Syndromes

Preleukemia

Ovarian Neoplasms

Pancreatic Neoplasms

Carcinoid Tumor

Ad5 Cea Vaccine

Lapatinib

Avastin And Tarceva

Hyperacute-Pancreas Immunotherapy

Dpx-0907 Consists Of 7 Tumor-Specific Hla-A2-Restricted Peptides, A Universal T Helper Peptide, A Polynucleotide Adjuvant, A Liposome And Montanide Isa51 Vg

Octreotide

Dher2 + As15 Asci

Pasireotide

Wt1 Derived Peptides

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo